Promoting Engagement and COVID-19 Testing for Health

NCT06141850 | Completed Results

• 2 other identifiers: STUDY000065311U01DK132737
• Study Type: interventional
• Target: 290
• Locations: 1 country
• Sites: 1

Brief Summary

PEACH2 is a community-based study, targeting individuals affected by diabetes. Study participants will be randomized into the PEACH2 Intervention Arm or the Control Arm. The intervention lasts for 16 weeks and participants will be followed for 12 months in total.

Conditions

COVID-19

Outcome Measures

Primary Outcomes (1)

• Number of Participants With Symptoms Who Use a COVID-19 Test

  The number of individuals who reported (1) having COVID or COVID-like symptoms and (2) taking a COVID-19 test in the past month as reported using survey data (baseline only) or the text-based COVID-19 reporting tool created for this study (weeks 4, 8, and 12).

  Baseline, Weeks 4, 8, and 12

Secondary Outcomes (2)

• Percent of Participants Receiving COVID-19 Vaccination

  Baseline, Week 16 (completion of intervention), and Month 12

• Number of Participants Adhering to COVID-19 Prevention Behaviors

  Baseline, Week 16 (completion of intervention), and Month 12

Study Arms (2)

Project PEACH2 Intervention

EXPERIMENTAL

In addition to a text-based reporting tool for reporting COVID-19 testing, participants randomized to the Project PEACH2 intervention will be sent weekly behavioral nudges via mobile phone text message to encourage adherence to COVID-19 testing and preventive behaviors.

Behavioral: COVID-19 Test Reporting; Behavioral: Personalized Nudges via Text Messaging

Control Group

ACTIVE COMPARATOR

Participants randomized to the control group will receive access to the text-based COVID-19 reporting tool and receive weekly texts on diabetes prevention, management or care.

Behavioral: COVID-19 Test Reporting; Behavioral: Non-personalized Nudges via Text Messaging

Interventions

COVID-19 Test Reporting BEHAVIORAL

Participants will use a simple text-based data reporting tool which they will be asked to use to report any COVID-19 testing during the 12-month long study.

Control Group; Project PEACH2 Intervention

Personalized Nudges via Text Messaging BEHAVIORAL

Weekly behavioral nudges via mobile phone text messages, personalized to participants' diabetes status, race/ethnicity, age group, sex, and/or vaccine/testing history, will be sent in weeks 1-16 of the intervention to encourage adherence to COVID-19 testing and preventive behaviors as well as other behaviors important for diabetes management, prevention, or care.

Project PEACH2 Intervention

Non-personalized Nudges via Text Messaging BEHAVIORAL

Weekly behavioral nudges via mobile phone text messages will be sent in weeks 1-16 of the intervention sharing tips lifestyle behaviors important for diabetes management and prevention (e.g., exercise, eating a healthy diet, etc.).

Control Group

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• English speaking
• Living in Georgia, USA
• Have access to a cellphone
• Not currently pregnant
• At-risk for diabetes, have diabetes, or are a family caregiver of someone living with diabetes
• Agree to receive text messages and be randomized to the intervention or control arm of the study

You may not qualify if:

• none

Sponsors & Collaborators

• Morehouse School of Medicine: collaborator
• Georgia Institute of Technology: collaborator
• Emory University: lead
• National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK): collaborator

Study Sites (1)

Emory University

Atlanta, Georgia, 30322, United States

Location

MeSH Terms

Conditions

COVID-19

Condition Hierarchy (Ancestors)

Pneumonia, Viral; Pneumonia; Respiratory Tract Infections; Infections; Virus Diseases; Coronavirus Infections; Coronaviridae Infections; Nidovirales Infections; RNA Virus Infections; Lung Diseases; Respiratory Tract Diseases

Results Point of Contact

• Title: Mary Beth Weber, PhD, MPH
• Organization: Emory University

mbweber@emory.edu

404-712-1902

Study Officials

• Mary Beth Weber, PhD, MPH

  Emory University

  PRINCIPAL INVESTIGATOR

Publication Agreements

• PI is Sponsor Employee: Yes

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: NONE
• Purpose: HEALTH SERVICES RESEARCH
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Associate Professor

Study Record Dates

• First Submitted: November 17, 2023
• First Posted: November 21, 2023
• Study Start: December 6, 2023
• Primary Completion: January 8, 2025
• Study Completion: March 25, 2025
• Last Updated: February 23, 2026
• Results First Posted: February 23, 2026

Record last verified: 2026-02

Data Sharing

• IPD Sharing: Will share
• Shared Documents: STUDY PROTOCOL, SAP, ICF, ANALYTIC CODE
• Time Frame: Data will be made available upon trial completion, with no end date.
• Access Criteria: Data will be available to anyone who wishes to access the data, for any purpose. Data will be available by emailing the study PI at mbweber@emory.edu or though the data repositories for the RADx-UP network.

Locations

US (1)